Please enable JavaScript to continue using this application.

Compare $IVVD vs $SION | Chartloom

Compare

$IVVD vs $SION

Invivyd Inc · Sionna Therapeutics Inc

IVVD

Invivyd Inc

SION

Sionna Therapeutics Inc

Compare $IVVD vs $SION

Comparing Invivyd Inc and Sionna Therapeutics Inc

IVVDInvivyd Inc

SIONSionna Therapeutics Inc

IVVDInvivyd Inc

Market cap

$212M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.13x

Rev growth (TTM)

26.3%

YTD performance

-71.2%

52W performance

-56.0%

FCF yield

-51.6%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IVVD

SION

Detailed metrics comparison

IVVD

Invivyd Inc

SION

Sionna Therapeutics Inc

Market Cap

IVVD$212M

SION$221M

Enterprise Value

IVVD$52M

SION$158M

Price

IVVD$0.72

SION$4.90

P/E Ratio

IVVDN/A

SIONN/A

P/S Ratio

IVVD3.64x

SION0.00x

EV/Sales

IVVD0.90x

SION0.00x

EV/EBITDA

IVVD0.00x

SION0.00x

P/B Ratio

IVVD1.34x

SION0.84x

P/FCF Ratio

IVVDN/A

SIONN/A

EV/FCF

IVVD-0.48x

SION-2.07x

PEG Ratio

IVVDN/A

SIONN/A

Forward P/E (NTM)

IVVDN/A

SIONN/A

Forward P/S (NTM)

IVVD3.13x

SIONN/A

Revenue (TTM)

IVVD$58M

SION$0

Revenue Growth (YoY)

IVVD26.3%

SIONN/A

Forward Rev Growth

IVVD44.8%

SION1297.1%

Gross Margin (TTM)

IVVD92.2%

SION0.0%

Operating Margin (TTM)

IVVD0.0%

SION0.0%

EBITDA Margin (TTM)

IVVD-191.7%

SION0.0%

Net Margin (TTM)

IVVD-183.9%

SION0.0%

FCF Margin (TTM)

IVVD-187.9%

SIONN/A

Net Income (TTM)

IVVD$-107M

SION$-97M

FCF (TTM)

IVVD$-110M

SION$-76M

EPS (TTM)

IVVD-$0.33

SION-$2.16

ROE (TTM)

IVVD-5973.0%

SION-3294.0%

ROA (TTM)

IVVD-4897.0%

SION-3108.0%

ROIC (TTM)

IVVD-5973.0%

SION-3294.0%

Cash

IVVD$160M

SION$63M

Debt

IVVD$0

SION$0

Net Cash/Debt

IVVD$160M

SION$63M

Current Ratio (TTM)

IVVD5.87x

SION20.05x

Quick Ratio (TTM)

IVVD5.60x

SION19.57x

Debt/Equity (TTM)

IVVD0.00x

SION0.00x

Debt/Assets (TTM)

IVVD0.0%

SION0.0%

Interest Coverage (TTM)

IVVDN/A

SIONN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

SION0.00x

Beta

IVVD1.32

SION1.44

52W Performance

IVVD-56.0%

SION-82.8%

YTD Performance

IVVD-71.2%

SION-87.5%

% from 52W High

IVVD-76.5%

SION-91.1%

% from 52W Low

IVVD36.7%

SION22.2%

Asset Turnover (TTM)

IVVD0.27x

SION0.00x

FCF Yield (TTM)

IVVD-51.6%

SION-34.4%

Earnings Yield (TTM)

IVVD-50.5%

SION-44.0%

Dividend Yield (TTM)

IVVDN/A

SIONN/A

Rule of 40

IVVD-161.6

SION0.0

EV/GP/RG

IVVD0.06

SIONN/A

Ticker research

View IVVD research View SION research

Metric	IVVD Invivyd Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$212M	$221M
Enterprise Value	$52M	$158M
Price	$0.72	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	0.00x
EV/Sales	0.90x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$58M	$0
Revenue Growth (YoY)	26.3%	N/A
Forward Rev Growth	44.8%	1297.1%
Profitability
Gross Margin (TTM)	92.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-191.7%	0.0%
Net Margin (TTM)	-183.9%	0.0%
FCF Margin (TTM)	-187.9%	N/A
Net Income (TTM)	$-107M	$-97M
FCF (TTM)	$-110M	$-76M
EPS (TTM)	-$0.33	-$2.16
ROE (TTM)	-5973.0%	-3294.0%
ROA (TTM)	-4897.0%	-3108.0%
ROIC (TTM)	-5973.0%	-3294.0%
Financial Health
Cash	$160M	$63M
Debt	$0	$0
Net Cash/Debt	$160M	$63M
Current Ratio (TTM)	5.87x	20.05x
Quick Ratio (TTM)	5.60x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	1.44
52W Performance	-56.0%	-82.8%
YTD Performance	-71.2%	-87.5%
% from 52W High	-76.5%	-91.1%
% from 52W Low	36.7%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-51.6%	-34.4%
Earnings Yield (TTM)	-50.5%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	0.0
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View SION research

Valuation

P/S Ratio

SION

0.00x

IVVD

3.64x

EV/FCF

SION

-2.07x

IVVD

-0.48x

Growth & revenue

Revenue Growth TTM

IVVD

26.3%

Forward Revenue Growth

SION

1297.1%

IVVD

44.8%

Profitability & performance

Gross Margin

IVVD

92.2%

SION

0.0%

ROE

SION

-3294.0%

IVVD

-5973.0%

FCF Yield %

SION

-34.4%

IVVD

-51.6%

52-Week Performance

IVVD

-56.0%

SION

-82.8%

Detailed metrics comparison

IVVD

Invivyd Inc

SION

Sionna Therapeutics Inc

Market Cap

IVVD$212M

SION$221M

Enterprise Value

IVVD$52M

SION$158M

Price

IVVD$0.72

SION$4.90

P/E Ratio

IVVDN/A

SIONN/A

P/S Ratio

IVVD3.64x

SION0.00x

EV/Sales

IVVD0.90x

SION0.00x

EV/EBITDA

IVVD0.00x

SION0.00x

P/B Ratio

IVVD1.34x

SION0.84x

P/FCF Ratio

IVVDN/A

SIONN/A

EV/FCF

IVVD-0.48x

SION-2.07x

PEG Ratio

IVVDN/A

SIONN/A

Forward P/E (NTM)

IVVDN/A

SIONN/A

Forward P/S (NTM)

IVVD3.13x

SIONN/A

Revenue (TTM)

IVVD$58M

SION$0

Revenue Growth (YoY)

IVVD26.3%

SIONN/A

Forward Rev Growth

IVVD44.8%

SION1297.1%

Gross Margin (TTM)

IVVD92.2%

SION0.0%

Operating Margin (TTM)

IVVD0.0%

SION0.0%

EBITDA Margin (TTM)

IVVD-191.7%

SION0.0%

Net Margin (TTM)

IVVD-183.9%

SION0.0%

FCF Margin (TTM)

IVVD-187.9%

SIONN/A

Net Income (TTM)

IVVD$-107M

SION$-97M

FCF (TTM)

IVVD$-110M

SION$-76M

EPS (TTM)

IVVD-$0.33

SION-$2.16

ROE (TTM)

IVVD-5973.0%

SION-3294.0%

ROA (TTM)

IVVD-4897.0%

SION-3108.0%

ROIC (TTM)

IVVD-5973.0%

SION-3294.0%

Cash

IVVD$160M

SION$63M

Debt

IVVD$0

SION$0

Net Cash/Debt

IVVD$160M

SION$63M

Current Ratio (TTM)

IVVD5.87x

SION20.05x

Quick Ratio (TTM)

IVVD5.60x

SION19.57x

Debt/Equity (TTM)

IVVD0.00x

SION0.00x

Debt/Assets (TTM)

IVVD0.0%

SION0.0%

Interest Coverage (TTM)

IVVDN/A

SIONN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

SION0.00x

Beta

IVVD1.32

SION1.44

52W Performance

IVVD-56.0%

SION-82.8%

YTD Performance

IVVD-71.2%

SION-87.5%

% from 52W High

IVVD-76.5%

SION-91.1%

% from 52W Low

IVVD36.7%

SION22.2%

Asset Turnover (TTM)

IVVD0.27x

SION0.00x

FCF Yield (TTM)

IVVD-51.6%

SION-34.4%

Earnings Yield (TTM)

IVVD-50.5%

SION-44.0%

Dividend Yield (TTM)

IVVDN/A

SIONN/A

Rule of 40

IVVD-161.6

SION0.0

EV/GP/RG

IVVD0.06

SIONN/A

Ticker research

View IVVD research View SION research

Metric	IVVD Invivyd Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$212M	$221M
Enterprise Value	$52M	$158M
Price	$0.72	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	0.00x
EV/Sales	0.90x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	N/A
Revenue & Growth
Revenue (TTM)	$58M	$0
Revenue Growth (YoY)	26.3%	N/A
Forward Rev Growth	44.8%	1297.1%
Profitability
Gross Margin (TTM)	92.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-191.7%	0.0%
Net Margin (TTM)	-183.9%	0.0%
FCF Margin (TTM)	-187.9%	N/A
Net Income (TTM)	$-107M	$-97M
FCF (TTM)	$-110M	$-76M
EPS (TTM)	-$0.33	-$2.16
ROE (TTM)	-5973.0%	-3294.0%
ROA (TTM)	-4897.0%	-3108.0%
ROIC (TTM)	-5973.0%	-3294.0%
Financial Health
Cash	$160M	$63M
Debt	$0	$0
Net Cash/Debt	$160M	$63M
Current Ratio (TTM)	5.87x	20.05x
Quick Ratio (TTM)	5.60x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	1.44
52W Performance	-56.0%	-82.8%
YTD Performance	-71.2%	-87.5%
% from 52W High	-76.5%	-91.1%
% from 52W Low	36.7%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.00x
FCF Yield (TTM)	-51.6%	-34.4%
Earnings Yield (TTM)	-50.5%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	0.0
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View SION research